Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple Sclerosis
Clinical trial NCT04879628 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04879628
- Sponsor
- Sanofi
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-07
- Primary completion
- 2022-09-21
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.